cysteine and Rheumatoid Arthritis

cysteine has been researched along with Rheumatoid Arthritis in 140 studies

Research

Studies (140)

Timeframe	Studies, this research(%)	All Research%
pre-1990	25 (17.86)	18.7374
1990's	40 (28.57)	18.2507
2000's	43 (30.71)	29.6817
2010's	28 (20.00)	24.3611
2020's	4 (2.86)	2.80

Authors

Authors	Studies
Frank, M	1
Li, CY; Li, Q; Wang, B; Yang, CM; Zhang, H; Zhang, Q	1
Dulubova, I; Eken, Y; Ferguson, DA; Hotema, M; Jiang, X; Lee, CI; Liu, L; McCauley, L; Reisman, SA; Trevino, I; Visnick, M; Wigley, WC; Wilson, AK	1
Bian, X; Hu, W; Liao, J; Wang, Z; Wu, J; Yu, Y; Zhu, YZ	1
Ali, L; Aspberg, A; Björkman, LI; Flowers, SA; Jin, C; Kalamajski, S; Karlsson, NG; Raj, JR	1
Castiglioni, L; Colazzo, F; Gelosa, P; Sironi, L; Tremoli, E	1
Fonović, M; Turk, B; Vizovišek, M	1
Hase, I; Ishii, Y; Kurasawa, K; Sakuma, H; Takizawa, H; Yamaguchi, B	1
Fukada, A; Nozue, T; Suda, T; Toyoshima, M	2
Kalemci, S; Sarıhan, A; Şimşek, A; Zeybek, A	1
Mitani, Y	1
Tanaka, E; Yamanaka, H	1
Amano, K; Kameda, H; Kishimoto, M; Kurasawa, T; Nagasawa, H; Takeuchi, T	1
Tamada, Y; Watanabe, D; Yanagishita, T	1
Abe, C; Funahashi, K; Katayama, K; Kondo, M; Matsubara, T; Matsuno, H; Okada, M; Sagawa, A; Sakai, Y; Yamasaki, K	1
Ito, S	2
Jia, WW; Liu, L; Liu, XH; Pan, LL; Shen, XY; Wu, WJ; Yang, D; Zhang, QY; Zhu, YZ	1
Arima, N; Endo, T; Ibaraki, H; Kanazawa, T; Seta, Y; Takashima, Y	1
Ideguchi, H; Ishigatsubo, Y; Nagaoka, S; Ohono, S; Soga, T; Suda, A	1
Hagihara, M; Hayashi, K; Miyasaka, N; Ogasawara, H; Tohda, S; Toi, H; Tojo, N	1
Arimitsu, J; Hagihara, K; Hirano, T; Kawai, M; Kawase, I; Kuwahara, Y; Nakanishi, K; Narazaki, M; Ogata, A; Shima, Y; Tanaka, T; Terabe, F	1
Hirohata, S; Tomita, T; Yanagida, T; Yoshikawa, H	1
Yamanaka, H	1
Mimori, T; Yukawa, N	1
Aono, H; Kageyama, M; Ohashi, K; Oki, K; Sasano, M; Tsuji, F	1
Abe, M; Kinoshita, M; Nakajima, M; Ohara, H; Ueda, N	1
Iwatani, M; Kobashigawa, T; Kotake, S; Nanke, Y; Yago, T; Yamanaka, H	1
Causey, CP; Cook, PF; Knuckley, B; Pellechia, PJ; Thompson, PR	1
Aono, H; Katsuta, O; Okamoto, M; Setoguchi, C; Tsuji, F	1
Komase, Y; Sakaida, H; Takemura, T	1
Amasaki, Y; Fujisaku, A; Ichikawa, K; Mukai, M; Ohnishi, K; Ohsaki, H; Sagawa, A; Shimizu, M; Yasuda, I	1
Bhabak, KP; Bhuyan, BJ; Mugesh, G	1
Kawai, S; Miyasaka, N; Takeuchi, T; Tanaka, Y; Yamamoto, K	1
Koyama, Y; Ohta, T; Shiraishi, H; Uchino, A	1
Amano, H; Kageyama, M; Kempe, K; Kusaoi, M; Matsudaira, R; Matsushita, M; Morimoto, S; Nawata, M; Ogasawara, M; Onuma, S; Sekiya, F; Tada, K; Takasaki, Y; Tamura, N; Toyama, S; Yamaji, K	1
Hirotoshi, K; Ikeda, K; Kawashima, H; Kobayashi, Y; Nakagomi, D; Nakajima, H; Suto, A	1
Ichikawa, N; Yamanaka, H	1
Kageyama, M; Kempe, K; Kon, T; Kusaoi, M; Matsudaira, R; Matsushita, M; Ogasawara, M; Onuma, S; Sekiya, F; Sugimoto, K; Tada, K; Takasaki, Y; Tamura, N; Yamaji, K	1
Tamura, N	1
Waring, RH; Wilkinson, LJ	1
Kumagai, N; Ono, K; Sakai, Y; Wakamatsu, S	1
FEDERICO, OM; HEIMER, R	1
Frick, B; Fuchs, D; Herold, M; Kaser, S; Ledochowski, M; Mur, E; Schroecksnadel, K; Wirleitner, B	1
Harada, T; Obayashi, M; Takahara, K; Uzu, T; Yamato, M; Yamauchi, A	1
Urata, Y	1
Hashimoto, S; Iwata, M; Nagai, C; Shimizu, Y; Takeda, T; Takeuchi, M; Uchiyama, S	1
Gomita, Y; Kawasaki, Y; Moriyama, M; Shibata, K	1
Kawabata, D; Mimori, T	1
Aoyama, M; Asai, K; Fukuoka, M; Kobayashi, M; Kusabe, T; Otsuka, T; Tanikawa, T; Waguri-Nagaya, Y	1
Asada, H; Izumi, A; Katsumi, S; Kobayashi, N; Miyagawa, S; Niizeki, H	1
Amano, K; Kameda, H; Sekiguchi, N; Takeuchi, T	1
Hara, S; Hoshino, J; Katori, H; Sawa, N; Suwabe, T; Tagami, T; Takaichi, K; Takemoto, F; Ubara, Y	1
Hur, JW; Lee, CW; Yoo, DH	1
Hokonohara, D; Kajiya, T; Kuroda, A; Tei, C	1
Yamamoto, T; Yokozeki, H	1
Hara, M; Inoue, E; Iwatani, M; Kamatani, N; Nakajima, A; Nakamura, T; Tomatsu, T; Yamanaka, H	1
Nakamura, K; Nakashima, T; Ochi, S; Oda, H; Suematsu, A; Tajiri, Y; Taka, J; Takayanagi, H; Tanaka, S	1
Itou, K; Kanazawa, T; Kuga, Y; Morishita, M; Tanida, K; Yokota, N	1
Matsuda, T; Ohtsubo, H	1
Abe, S; Azuma, A; Fukuda, Y; Kudoh, S; Nakayama, T; Nei, T; Saito, Y; Usuki, J	1
Fukushima, K; Gono, T; Ikeda, S; Katoh, N; Matsuda, M; Mitsuhashi, S; Takei, Y	1
Fujimura, M; Kasahara, K; Nakao, S; Nakatsumi, Y; Tambo, Y; Yasui, M	1
Makino, F; Mochizuki, H; Morioka, T; Ogiwara, Y; Sugihara, T; Takahashi, H	1
Emery, P; Huston, G; Idle, JR; Mitchell, SC; Panayi, GS; Shah, RR; Smith, RL; Waring, RH; Welsh, KI	1
Johnson, S; Kaung, C; Roboz, J; Yu, TF	1
Ament, HJ; Henrichs, AM; Muijsers, AO; van de Stadt, RJ; van der Korst, JK	2
Butler, M; Carruthers, G; Freeman, D; Harth, M; Rothwell, R; Weir, D	1
Ishizaki, C; Kohsokabe, S; Nishida, H; Sueki, H	1
Brooks, P; Conaghan, PG	1
Ando, J; Hiramatsu, K; Inokuma, S; Matsuzaki, Y; Miyakuni, Y; Shiratori, K	1
Brooks, P; Conaghan, PG; Girgis, L	1
Rafter, GW	1
Hashimoto, M; Hiramatsu, K; Hosaka, M; Iwabuchi, H; Kaga, S; Kanemitsu, H; Kasama, T; Matsuda, A; Negishi, M; Yamazaki, J	1
Ichibangase, Y; Ohtsuka, E; Oribe, M; Sakai, K; Shiokawa, S; Takahashi, H; Wada, T; Yamamoto, M; Yasuda, M; Yoshioka, K	1
Kitano, T; Matsuno, H; Matsushita, I; Ochiai, H; Tsuji, H	1
Fukumoto, M; Okamoto, M; Suda, H	1
Ando, J; Inokuma, S; Ito, K; Kiyosawa, H; Kobayashi, S; Nozawa, F; Sakata, M	1
Hirohata, S; Inoue, T; Ito, K; Iwamoto, S; Kawashima, C; Kisaki, T; Nishioka, Y; Sawada, T; Shinohara, S; Tohma, S	1
Doyle, DV; Ensor, M; Foster, OJ; Perrett, D; Scott, DL	1
In, H; Ito, S; Kikuchi, M; Nakano, M; Ozawa, T; Saeki, T; Saito, T; Sato, T; Suzuki, S; Ueno, M	1
Hashimoto, K; Lipsky, PE	1
Nobunaga, M; Yasuda, M	1
Hirohata, S; Lipsky, PE	1
Hayakawa, M; Ikoma, T; Inokuma, S; Inoue, S; Negishi, M; Satou, T; Sayama, T; Shimizu, H; Ueda, A; Urano, Y	1
Inokuma, S; Kiyosawa, H; Sakata, M; Shiratori, K; Yoshida, A	1
Arakawa, M; Hasegawa, H; Nakano, M; Nishi, S; Saito, T; Ueno, M	1
Furukawa, H; Hashimoto, S; Inoue, T; Ito, K; Sawada, T; Tohma, S	1
Kim, HA; Song, YW	1
Hashimoto, H; Hirohata, S; Nakamura, H; Ochi, T; Tomita, T; Yanagida, T; Yoshino, S	1
Houki, N; Ichibangase, Y; Nobunaga, M; Yamamoto, M; Yasuda, M	1
Kawada, A; Kimura, M	1
Kubo, T; Matsuno, H; Matsuura, K; Muraguchi, A; Nezuka, T; Sugiyama, E; Tsuji, H	1
De Miguel, E; Hernanz, A; Martín-Mola, E; Plaza, A	1
Hara, S; Hideyuki, K; Mikami, A; Mori, T; Nakase, K; Sawa, N; Tachibana, S; Tagami, T; Takemoto, F; Ubara, Y; Yamada, A; Yokoyama, K	1
Blake, DR; Grootveld, M; Lynch, EJ; Patel, IY; Silwood, CJ	1
Kumagai, S; Morinobu, A; Wang, Z	1
Hirata, D; Iwamoto, M; Kamimura, T; Kano, S; Masuyama, JI; Mimori, A; Minota, S; Okazaki, H; Sato, H; Yoshio, T	1
Hefferton, D; Rahman, P; Robb, D	1
Asano, G; Nagashima, M; Yoshino, S	1
Aono, H; Hirano, D; Ishigami, S; Nagashima, M; Sasano, M; Takai, M; Wauke, K; Yoshino, S	1
Kanazawa, M; Kawabata, Y; Matsushima, H; Motegi, M; Sakamoto, T; Sugita, Y; Takayanagi, N; Ubukata, M; Yanagisawa, T	1
Hla, T; Inoue , K; Kawahito, Y; Kohno, M; Sano, H; Tsubouchi, Y	1
Ji, JD; Kang, KH; Kim, HK; Kim, YR; Lee, JH; Lee, YH; Shim, JJ; Song, GG	1
Hara, M; Hara, S; Matsushita, H; Nagahama, K; Ubara, Y; Yamada, A	1
Hanaoka, R; Hanyuda, M; Ide, H; Kaga, S; Kasama, T; Miwa, Y; Negishi, M; Shiozawa, F	1
Fujii, K; Kishimoto, N	1
Maini, RN; Roffe, L; Room, G	1
Kretzschmar, R; Worstmann, W	1
Goto, K; Nakahara, K; Tanaka, H	1
Fujinami, T; Koyama, K; Morozumi, K; Oikawa, T; Takeda, A; Yoshida, A	1
Arai, T; Fujigaki, Y; Hishida, A; Ikegaya, N; Isozaki, T; Kaneko, E; Kimura, M	1
Eguchi, K; Fukuda, T; Ida, H; Ishimaru, T; Kawakami, A; Nakashima, M; Sakai, M; Shimada, H; Terada, K; Yamashita, I	1
Emery, P; Waring, RH	1
Fukushima, T; Hashimoto, M; Ide, H; Kaga, S; Kasama, T; Kobayashi, K; Negishi, M; Tabata, M; Takahashi, T; Yamagata, N	1
Fujinami, T; Ikeda, M; Koyama, K; Morozumi, K; Oikawa, T; Suganuma, T; Sugito, K; Takeda, A; Yoshida, A	1
Arimori, S; Ichikawa, Y; Shimizu, H	1
Amasaki, Y; Atsumi, T; Fujisaku, A; Jodo, S; Kobayashi, H; Mukai, M; Nakabayashi, T; Nakagawa, S; Sagawa, A; Watanabe, I	1
Baba, N; Nomura, T; Sakemi, T; Uchida, M; Watanabe, T	1
Baggott, JE; Morgan, SL; Refsum, H; Ueland, PM	1
Iwainaka, Y; Kawano, M; Koni, I; Nakashima, A; Nomura, H; Takeda, R; Tofuku, Y	1
Goto, M; Nishioka, K; Sasano, M	1
Hidano, A; Oryu, F; Yamaguchi, R	1
Bird, HA; Dixon, JS; Martin, MF; McKenna, F; Wright, V	1
Ishikawa, K; Sakaguchi, M	1
Baker, LR; Greenwood, RN; Matthey, F; Perrett, D	1
Beyer, J; Boesen, PD; Helin, P; Hørslev-Petersen, K	1
Bird, H; Dixon, J; Hickling, P; McKenna, F	1
Danielewicz, H; Kosowska, E	1
Dancewicz, AM; Sopata, I	1
Roszkowski-Sliz, W; Ryzewski, J	1
Markiewicz, L; Michalak, E; Ryźewski, J	1
Calick, A; Fabianek, J; Herp, A; Pigman, W	1
Kosaka, S	2
Krzymien, H	1
Brown, JH; Mackey, HK	1
Anderson, AJ	1

Reviews

21 review(s) available for cysteine and Rheumatoid Arthritis

Article	Year
Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases. Mediators of inflammation, 2017, Volume: 2017 Topics: Animals; Arthritis, Rheumatoid; Cardiovascular Diseases; Central Nervous System Diseases; Cysteine; Dermatitis, Atopic; Humans; Leukotrienes; Neurodegenerative Diseases	2017
Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond. Matrix biology : journal of the International Society for Matrix Biology, 2019, Volume: 75-76 Topics: Arthritis, Rheumatoid; Cathepsins; Cysteine; Cysteine Endopeptidases; Extracellular Matrix; Heart Diseases; Humans; Inflammation; Lysosomes; Neoplasms; Proteolysis	2019
[DMARDs (disease-modifying antirheumatic drugs)]. Nihon rinsho. Japanese journal of clinical medicine, 2013, Volume: 71, Issue:7 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Humans; Japan; Methotrexate; Sulfasalazine; Tacrolimus	2013
[DMARDs (Focusing on iguratimod)]. Nihon rinsho. Japanese journal of clinical medicine, 2016, Volume: 74, Issue:6 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cysteine; Drug Discovery; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Drugs, Generic; Female; Humans; Male; Ribonucleosides; Sulfasalazine; Sulfonamides; Tacrolimus	2016
[Antirheumatic agents for treatment of rheumatoid arthritis]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2008, Oct-10, Volume: 97, Issue:10 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Pharmacogenetics; Randomized Controlled Trials as Topic; Remission Induction; Sulfasalazine; Time Factors	2008
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis]. Clinical calcium, 2009, Volume: 19, Issue:3 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus	2009
Bucillamine-induced yellow nail in Japanese patients with rheumatoid arthritis: two case reports and a review of 36 reported cases. Rheumatology international, 2013, Volume: 33, Issue:3 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Male; Yellow Nail Syndrome	2013
[Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 6. Bucillamine and gold (gold sodium thiomalate and auranofin)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2011, Oct-10, Volume: 100, Issue:10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Cysteine; Gold Sodium Thiomalate	2011
[ Bone and cartilage destruction in RA and its intervention. Disease-modifying antirheumatic drugs]. Clinical calcium, 2012, Volume: 22, Issue:2 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Cartilage; Clinical Trials as Topic; Cysteine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Sulfasalazine; Tacrolimus	2012
[Bucillamine-induced dermatomyositis-like clinical features in a patient with rheumatoid arthritis]. Rinsho shinkeigaku = Clinical neurology, 2005, Volume: 45, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Dermatomyositis; Female; Humans	2005
[Disease modifying anti-rheumatic drugs (DMARDs): an overview]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 1 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Benzopyrans; Cysteine; Evidence-Based Medicine; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Meta-Analysis as Topic; Methotrexate; Randomized Controlled Trials as Topic; Sulfasalazine; Sulfonamides	2005
Bucillamine-induced toxic epidermal necrolysis and fixed drug eruption. The Journal of dermatology, 2005, Volume: 32, Issue:5 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biopsy, Needle; Cysteine; Drug Eruptions; Female; Follow-Up Studies; Humans; Immunohistochemistry; Long-Term Care; Middle Aged; Risk Assessment; Severity of Illness Index; Stevens-Johnson Syndrome	2005
[Effective combination therapy of TNF antagonists with DMARDs]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Volume: 65, Issue:7 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cysteine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Tumor Necrosis Factor-alpha	2007
A case with life-threatening interstitial pneumonia associated with bucillamine treatment. Modern rheumatology, 2008, Volume: 18, Issue:5 Topics: Aged, 80 and over; Antioxidants; Arthritis, Rheumatoid; Cysteine; Female; Humans; Lung Diseases, Interstitial	2008
Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine. Current opinion in rheumatology, 1995, Volume: 7, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cysteine; Drug Therapy, Combination; Gold; Humans; Methotrexate; Penicillamine; Sulfasalazine	1995
Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine. Current opinion in rheumatology, 1994, Volume: 6, Issue:3 Topics: Age Factors; Antimalarials; Arthritis, Rheumatoid; Clinical Trials as Topic; Cysteine; Digestive System; Gold; Humans; Liver; Methotrexate; Penicillamine; Sulfasalazine	1994
[Drug-induced renal disorders in patients with rheumatoid arthritis]. Ryumachi. [Rheumatism], 1996, Volume: 36, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Humans; Kidney Diseases; Methotrexate; ortho-Aminobenzoates	1996
[A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2002, Volume: 40, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Drug Eruptions; Female; Humans; Lung; Middle Aged; Pulmonary Eosinophilia	2002
Bucillamine (a new therapeutic agent for rheumatoid arthritis) induced nephrotic syndrome: a report of two cases and review of the literature. The Clinical investigator, 1992, Volume: 70, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nephrotic Syndrome; Structure-Activity Relationship; Sulfhydryl Compounds	1992
Management of early inflammatory arthritis. Genetic factors predicting persistent disease: the role of defective enzyme systems. Bailliere's clinical rheumatology, 1992, Volume: 6, Issue:2 Topics: Acetaminophen; Arthritis, Rheumatoid; Carbocysteine; Cysteine; Forecasting; Humans; Inactivation, Metabolic; Methylation; Methyltransferases; Oxidation-Reduction; Sulfates	1992
"Yellow nail syndrome" and rheumatoid arthritis. The Tokai journal of experimental and clinical medicine, 1991, Volume: 16, Issue:5-6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Male; Middle Aged; Nail Diseases; Nails; Penicillamine; Syndrome	1991

Trials

12 trial(s) available for cysteine and Rheumatoid Arthritis

Article	Year
Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: an open, randomized, controlled trial. Modern rheumatology, 2014, Volume: 24, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Disease Progression; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Treatment Outcome; Young Adult	2014
A comparative study of the effects of bucillamine and salazosulfapyridine in the treatment of rheumatoid arthritis. Modern rheumatology, 2009, Volume: 19, Issue:4 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cysteine; Drug Therapy, Combination; Female; Hand Strength; Health Status; Humans; Joints; Male; Middle Aged; Pain; Prednisolone; Severity of Illness Index; Sulfasalazine; Time Factors; Treatment Outcome	2009
A multicentre trial of bucillamine in the treatment of early rheumatoid arthritis (SNOW study). Modern rheumatology, 2011, Volume: 21, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Cysteine; Early Diagnosis; Female; Humans; Male; Methotrexate; Middle Aged; Patient Dropouts; Remission Induction; Treatment Outcome; Young Adult	2011
Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs--a multicenter, double-blind, parallel-group trial. Modern rheumatology, 2011, Volume: 21, Issue:5 Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Joints; Male; Methotrexate; Middle Aged; Severity of Illness Index; Sulfasalazine; Tacrolimus; Treatment Outcome	2011
Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis. Clinical and experimental nephrology, 2003, Volume: 7, Issue:4 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Disease Progression; Dose-Response Relationship, Drug; Female; Glomerulonephritis, Membranous; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Proteinuria	2003
Efficacy profile of bucillamine in rheumatoid arthritis patients in a large observational cohort study, IORRA. Modern rheumatology, 2006, Volume: 16, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cohort Studies; Cysteine; Drug Therapy, Combination; Female; Health Status; Humans; Joints; Male; Methotrexate; Middle Aged; Pain; Prednisolone; Prospective Studies; Remission Induction; Severity of Illness Index; Sulfasalazine	2006
Efficacy of additive DMARD therapy in patients with rheumatoid arthritis. Double blind controlled trial using bucillamine and placebo with maintenance doses of gold sodium thiomalate. The Journal of rheumatology, 1994, Volume: 21, Issue:1 Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Child, Preschool; Cysteine; Double-Blind Method; Drug Combinations; Female; Gold Sodium Thiomalate; Humans; Life Tables; Male; Middle Aged; Placebos; Prospective Studies; Time Factors; Treatment Outcome	1994
Comparison of clinical effects of bucillamine between additive combination and single administration study in rheumatoid arthritis. Agents and actions. Supplements, 1993, Volume: 44 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Double-Blind Method; Drug Therapy, Combination; Humans	1993
A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis. Rheumatology international, 1997, Volume: 17, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Female; Humans; Male; Middle Aged; Penicillamine	1997
Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate. Clinical pharmacology and therapeutics, 1991, Volume: 50, Issue:5 Pt 1 Topics: Arthritis, Rheumatoid; Cysteine; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Methotrexate	1991
SA 96 (N-(2-mercapto-2-methylpropanoyl)-L-cysteine) in rheumatoid arthritis. Scandinavian journal of rheumatology, 1986, Volume: 15, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Cysteine; Drug Eruptions; Elasticity; Female; Gold; Humans; Middle Aged; Penicillamine; Tensile Strength; Time Factors	1986
Rheumatoid arthritis: supplemental L-cysteine in penicillamine treatment--a controlled study. The Journal of rheumatology, 1985, Volume: 12, Issue:3 Topics: Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Cysteine; Female; Humans; Male; Middle Aged; Penicillamine	1985

Other Studies

107 other study(ies) available for cysteine and Rheumatoid Arthritis

Article	Year
Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank. Future microbiology, 2022, Volume: 17 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials, Phase III as Topic; COVID-19; COVID-19 Drug Treatment; Cysteine; Drug Industry; Drug Repositioning; Gout; Humans	2022
[Mechanism of active ingredients in Periploca forrestii compound against rheumatoid arthritis based on integrative metabolomics and network pharmacology]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2023, Volume: 48, Issue:2 Topics: Animals; Arthritis, Rheumatoid; Biomarkers; Chromatography, High Pressure Liquid; Cysteine; Cytidine Diphosphate Choline; Glycerophospholipids; Metabolomics; Methionine; Network Pharmacology; Periploca; Phosphorylcholine; Purines; Rats	2023
A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt. Bioorganic & medicinal chemistry letters, 2020, 03-15, Volume: 30, Issue:6 Topics: Allosteric Site; Animals; Arthritis, Rheumatoid; Cell Differentiation; Collagen; Cysteine; Disease Models, Animal; Humans; Hydroxycholesterols; Interleukin-17; Ligands; Mice; Molecular Dynamics Simulation; Mutagenesis; Nuclear Receptor Subfamily 1, Group F, Member 3; Protein Binding; Protein Conformation; Pyrimidines; Structure-Activity Relationship; Th17 Cells	2020
S-Propargyl-Cysteine Remodels the Gut Microbiota to Alleviate Rheumatoid Arthritis by Regulating Bile Acid Metabolism. Frontiers in cellular and infection microbiology, 2021, Volume: 11 Topics: Animals; Arthritis, Rheumatoid; Bile Acids and Salts; Cysteine; Gastrointestinal Microbiome; Male; Rats; Rats, Sprague-Dawley; RNA, Ribosomal, 16S	2021
Cartilage oligomeric matrix protein forms protein complexes with synovial lubricin via non-covalent and covalent interactions. Osteoarthritis and cartilage, 2017, Volume: 25, Issue:9 Topics: Arthritis; Arthritis, Rheumatoid; Binding Sites; Cartilage Oligomeric Matrix Protein; Cartilage, Articular; Cysteine; Glycoproteins; Humans; Osteoarthritis; Protein Binding; Spondylarthritis; Synovial Fluid	2017
Hyperplasia of Lymphoid Follicles and Lymphangiectasia in the Parietal Pleura in Bucillamine-induced Yellow Nail Syndrome. Internal medicine (Tokyo, Japan), 2018, Jul-01, Volume: 57, Issue:13 Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Hyperplasia; Inflammation; Lymphangiectasis; Lymphedema; Pleurisy; Yellow Nail Syndrome	2018
Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature. Internal medicine (Tokyo, Japan), 2019, Aug-01, Volume: 58, Issue:15 Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Bronchoalveolar Lavage Fluid; Cysteine; Dyspnea; Female; Humans; Hypoxia; Lung; Lung Diseases, Interstitial; Lymphocyte Count; Pneumonia; Tomography, X-Ray Computed	2019
Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature. Internal medicine (Tokyo, Japan), 2019, 12-01, Volume: 58, Issue:23 Topics: Arthritis, Rheumatoid; Cysteine; Humans; Lung Diseases, Interstitial; Patients; Pneumonia	2019
Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature - Reply. Internal medicine (Tokyo, Japan), 2019, 12-01, Volume: 58, Issue:23 Topics: Arthritis, Rheumatoid; Cysteine; Humans; Lung Diseases, Interstitial; Patients; Pneumonia	2019
Effective treatment of a steroid-induced femoral neck fracture nonunion with a once-weekly administration of teriparatide in a rheumatoid patient: a case report. Archives of osteoporosis, 2013, Volume: 8 Topics: Aged, 80 and over; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone Density Conservation Agents; Cysteine; Female; Femoral Neck Fractures; Fractures, Ununited; Glucocorticoids; Humans; Osteoporosis; Prednisolone; Teriparatide; Treatment Outcome	2013
Bucillamine-induced pemphigus vulgaris. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:6 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Drug Eruptions; Female; Humans; Pemphigus	2015
The usefulness of a new triple combination treatment utilizing methotrexate, salazosulfapyridine, and bucillamine in rheumatoid arthritis. Modern rheumatology, 2016, Volume: 26, Issue:1 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cysteine; Drug Therapy, Combination; Female; Humans; Japan; Male; Methotrexate; Middle Aged; Sulfasalazine; Treatment Outcome	2016
S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway. Redox biology, 2016, Volume: 10 Topics: Animals; Anti-Inflammatory Agents; Antioxidant Response Elements; Arthritis, Rheumatoid; Cell Line; Cell Movement; Cell Survival; Cysteine; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Male; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Up-Regulation	2016
Systemic delivery of small interfering RNA targeting nuclear factor κB in mice with collagen-induced arthritis using arginine-histidine-cysteine based oligopeptide-modified polymer nanomicelles. International journal of pharmaceutics, 2016, Dec-30, Volume: 515, Issue:1-2 Topics: Animals; Arginine; Arthritis, Experimental; Arthritis, Rheumatoid; Collagen; Cysteine; Cytokines; Disease Models, Animal; Histidine; Inflammation; Male; Mice; Mice, Inbred DBA; Micelles; Nanoparticles; NF-kappa B; Oligopeptides; Polymers; RNA, Messenger; RNA, Small Interfering; Synovial Membrane; Synoviocytes; Transcription Factor RelA	2016
The efficacy and safety of bucillamine as a second-line DMARD in the treatment of rheumatoid arthritis: a retrospective cohort study. Modern rheumatology, 2008, Volume: 18, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Cysteine; Female; Health Status; Humans; Joints; Male; Middle Aged; Remission Induction; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2008
[False-positive reaction of urinary ketone bodies caused by bucillamine]. Rinsho byori. The Japanese journal of clinical pathology, 2008, Volume: 56, Issue:7 Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Cysteine; False Positive Reactions; Female; Humans; Ketone Bodies; Male; Middle Aged	2008
Etanercept improved primary biliary cirrhosis associated with rheumatoid arthritis. Joint bone spine, 2009, Volume: 76, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Prednisolone; Receptors, Tumor Necrosis Factor; Treatment Outcome; Withholding Treatment	2009
Differential influences of bucillamine and methotrexate on the generation of fibroblast-like cells from bone marrow CD34+ cells of rheumatoid arthritis patients. International immunopharmacology, 2009, Volume: 9, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD34; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow Cells; Culture Media; Cysteine; Female; Fibroblasts; Fluorescent Antibody Technique; Humans; Ilium; Immunosuppressive Agents; Indicators and Reagents; Matrix Metalloproteinase 1; Methotrexate; Middle Aged; Stem Cells; Vimentin	2009
The investigation of synovial genomic targets of bucillamine with microarray technique. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2009, Volume: 58, Issue:9 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Cysteine; Gene Expression Profiling; Gene Expression Regulation; Humans; Interleukin-1beta; Microarray Analysis; Molecular Sequence Data; Molecular Structure; Signal Transduction; Synovial Membrane	2009
Radiographic repair in three Japanese patients with rheumatoid arthritis treated with bucillamine. Modern rheumatology, 2009, Volume: 19, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Arthrography; Bone and Bones; Cysteine; Disease Progression; Female; Humans; Joints; Male; Middle Aged; Recovery of Function; Severity of Illness Index; Treatment Outcome	2009
Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation. Chembiochem : a European journal of chemical biology, 2010, Jan-25, Volume: 11, Issue:2 Topics: Acids; Amidines; Arthritis, Rheumatoid; Catalysis; Catalytic Domain; Cysteine; Humans; Hydrogen-Ion Concentration; Hydrolases; Kinetics; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases	2010
Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model. Modern rheumatology, 2010, Volume: 20, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cysteine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Etanercept; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Immunoglobulin G; Immunoglobulin M; Interleukin-1alpha; Interleukin-6; Rats; Rats, Inbred Lew; Receptors, Tumor Necrosis Factor	2010
Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept. Modern rheumatology, 2010, Volume: 20, Issue:6 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cryptogenic Organizing Pneumonia; Cysteine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Methotrexate; Middle Aged; Radiography, Thoracic; Receptors, Tumor Necrosis Factor; Treatment Outcome	2010
Bioinorganic and medicinal chemistry: aspects of gold(I)-protein complexes. Dalton transactions (Cambridge, England : 2003), 2011, Mar-14, Volume: 40, Issue:10 Topics: Arthritis, Rheumatoid; Binding Sites; Catalytic Domain; Chemistry, Pharmaceutical; Coordination Complexes; Cysteine; Glutathione Reductase; Gold; Humans; Protein Tyrosine Phosphatases; Proteins; Selenocysteine; Serum Albumin	2011
Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate. Modern rheumatology, 2012, Volume: 22, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Drug Substitution; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Humans; Immunoglobulin G; Joints; Male; Methotrexate; Middle Aged; Pain Measurement; Receptors, Tumor Necrosis Factor; Recovery of Function; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Treatment Failure	2012
Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritis. Clinical rheumatology, 2012, Volume: 31, Issue:2 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Disease Progression; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Severity of Illness Index; Sulfasalazine; Tacrolimus; Treatment Outcome	2012
Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan. Modern rheumatology, 2012, Volume: 22, Issue:6 Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Drug Therapy, Combination; Female; Humans; Japan; Male; Methotrexate; Practice Patterns, Physicians'; Severity of Illness Index; Sulfasalazine; Treatment Outcome	2012
[Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment; 2. Antirheumatic agents, 1) non-biologic agents]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Oct-10, Volume: 101, Issue:10 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Female; Humans; Methotrexate; Sulfasalazine; Tacrolimus	2012
Cysteine dioxygenase: modulation of expression in human cell lines by cytokines and control of sulphate production. Toxicology in vitro : an international journal published in association with BIBRA, 2002, Volume: 16, Issue:4 Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Cell Line; Cysteine; Cysteine Dioxygenase; Dioxygenases; Humans; Inflammation; Liver; Neurons; Oxygenases; Sulfates; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2002
Gigantomastia induced by bucillamine. Annals of plastic surgery, 2002, Volume: 49, Issue:2 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Breast; Breast Diseases; Cysteine; Female; Humans; Hyperplasia; Hypertrophy; Mammaplasty; Treatment Outcome	2002
Depolymerization of the 19S antibodies and the 22S rheumatoid factor. Clinica chimica acta; international journal of clinical chemistry, 1958, Volume: 3, Issue:5 Topics: Antibodies; Arthritis; Arthritis, Rheumatoid; Cysteine; Humans; Rheumatoid Factor	1958
Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis. Clinica chimica acta; international journal of clinical chemistry, 2003, Volume: 338, Issue:1-2 Topics: Adult; Aged; Antigens, CD; Arthritis, Rheumatoid; Cysteine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Vitamin B 12	2003
Patients with rheumatoid arthritis (RA) and proteinuria. Clinical and experimental nephrology, 2004, Volume: 8, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Humans; Proteinuria	2004
[Examination of the escape phenomenon in disease modifying antirheumatic drugs]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:3 Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Cysteine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Phenylacetates; Recurrence; Secondary Prevention; Sulfasalazine	2005
The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes. Rheumatology international, 2005, Volume: 25, Issue:8 Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cells; Cells, Cultured; Cysteine; Dexamethasone; Elbow; Female; Fibroblasts; Humans; Knee; Methotrexate; Middle Aged; Organogold Compounds; Orthopedic Procedures; Penicillamine; Phenylacetates; Sulfasalazine; Synovial Membrane; Thymidine Phosphorylase	2005
Efficacy and safety of bucillamine, a D-penicillamine analogue, in patients with active rheumatoid arthritis. Modern rheumatology, 2006, Volume: 16, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; C-Reactive Protein; Cysteine; Female; Humans; Joints; Male; Methotrexate; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2006
Outcome and treatment of bucillamine-induced nephropathy. Nephron. Clinical practice, 2006, Volume: 104, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Drug Administration Schedule; Female; Glomerulonephritis, Membranous; Humans; Kidney; Male; Middle Aged; Proteinuria; Remission Induction	2006
Bucillamine-induced pemphigus vulgaris in a patient with rheumatoid arthritis and polymyositis overlap syndrome. Journal of Korean medical science, 2006, Volume: 21, Issue:3 Topics: Antioxidants; Arthritis; Arthritis, Rheumatoid; Biopsy; Cysteine; Female; Humans; Middle Aged; Pemphigus; Polymyositis; Skin; Syndrome	2006
Radiographic appearance of bronchiolitis obliterans organizing pneumonia (BOOP) developing during Bucillamine treatment for rheumatoid arthritis. The American journal of the medical sciences, 2006, Volume: 332, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cryptogenic Organizing Pneumonia; Cysteine; Female; Humans; Lung; Radiography	2006
Yellow nails under bucillamine therapy for rheumatoid arthritis: a report of two cases. Rheumatology international, 2007, Volume: 27, Issue:6 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Middle Aged; Nail Diseases; Pigmentation Disorders	2007
Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis. Modern rheumatology, 2007, Volume: 17, Issue:1 Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Resorption; Cell Differentiation; Cells, Cultured; Coculture Techniques; Cysteine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Methotrexate; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; RANK Ligand; Sulfasalazine	2007
Ten years results of bucillamine in the treatment of rheumatoid arthritis. Modern rheumatology, 2007, Volume: 17, Issue:1 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Cysteine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Dropouts; Severity of Illness Index; Treatment Outcome	2007
A case of bucillamine-induced interstitial pneumonia with positive lymphocyte stimulation test for bucillamine using bronchoalveolar lavage lymphocytes. Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:20 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Bronchoalveolar Lavage Fluid; Cysteine; Female; Humans; Lung; Lung Diseases, Interstitial; Lymphocyte Activation; Middle Aged; Radiography	2007
Hemophagocytic syndrome associated with rheumatoid arthritis. Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:21 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Middle Aged	2007
Eosinophilic pneumonia (EP) associated with rheumatoid arthritis in which drug-induced eosinophilic pneumonia could be ruled out. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:6 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Diagnosis, Differential; Glucocorticoids; Humans; Male; Methotrexate; Prednisolone; Pulmonary Eosinophilia	2008
D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3. The Journal of rheumatology, 1984, Volume: 11, Issue:5 Topics: Adult; Aged; Arthritis, Rheumatoid; Biotransformation; Carbocysteine; Cysteine; Female; Histocompatibility Antigens Class II; HLA-DR3 Antigen; HLA-DR4 Antigen; Humans; Male; Middle Aged; Penicillamine; Risk	1984
Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis. The Journal of rheumatology, 1984, Volume: 11, Issue:4 Topics: Arthritis, Rheumatoid; Cysteine; Cystinuria; Drug Therapy, Combination; Female; Humans; Male; Penicillamine; Pilot Projects; Probenecid; Time Factors	1984
D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects. Arthritis and rheumatism, 1984, Volume: 27, Issue:12 Topics: Arthritis, Rheumatoid; Cysteine; Drug Administration Schedule; Humans; Intestinal Absorption; Kinetics; Penicillamine; Time Factors	1984
Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis. Clinical and investigative medicine. Medecine clinique et experimentale, 1984, Volume: 7, Issue:1 Topics: Adult; Aged; Arthritis, Rheumatoid; Biotransformation; Chromatography, High Pressure Liquid; Cysteine; Dose-Response Relationship, Drug; Female; Humans; Metabolic Clearance Rate; Middle Aged; Penicillamine	1984
Yellow nail induced by bucillamine. International journal of dermatology, 1995, Volume: 34, Issue:7 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Humans; Male; Nail Diseases	1995
[Immunoglobulin and LST in RA patients treated with bucillamine]. Ryumachi. [Rheumatism], 1995, Volume: 35, Issue:1 Topics: Aged; Arthritis, Rheumatoid; Cysteine; Female; Humans; Immunoglobulins; Lymphocyte Activation; Male; Middle Aged	1995
Plasma thiols, copper and rheumatoid arthritis. Medical hypotheses, 1994, Volume: 43, Issue:1 Topics: Animals; Arthritis, Rheumatoid; Copper; Cysteine; Glutathione; Homocysteine; Humans; Methionine; Methotrexate; Models, Biological; Sulfhydryl Compounds	1994
[A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment]. Ryumachi. [Rheumatism], 1994, Volume: 34, Issue:3 Topics: Agranulocytosis; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Middle Aged	1994
Immunopharmacological evaluation of bucillamine in rheumatoid arthritis. Drugs under experimental and clinical research, 1993, Volume: 19, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; CD4 Antigens; Cysteine; Female; Flow Cytometry; Hemagglutination Tests; Humans; Male; Middle Aged; T-Lymphocyte Subsets	1993
Delayed-type skin allergic reaction in guinea pigs induced by anti-rheumatic compounds with sulfhydryl groups. Immunopharmacology and immunotoxicology, 1993, Volume: 15, Issue:4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Dermatitis, Allergic Contact; Drug Hypersensitivity; Guinea Pigs; Humans; Hypersensitivity, Delayed; Immunochemistry; Male; Species Specificity; Structure-Activity Relationship; Sulfhydryl Compounds	1993
[Immunoglobulin decrease accompanying adverse reactions with bucillamine]. Ryumachi. [Rheumatism], 1993, Volume: 33, Issue:4 Topics: Agammaglobulinemia; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged	1993
[Analysis of the state of patients with rheumatoid arthritis using a personal computer]. Ryumachi. [Rheumatism], 1993, Volume: 33, Issue:2 Topics: Age Factors; Arthritis, Rheumatoid; Cysteine; Databases, Factual; Female; Gold Sodium Thiomalate; Humans; Male; Microcomputers; Middle Aged; Penicillamine; Quality of Life; Time Factors	1993
The long-term use of D-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary? British journal of rheumatology, 1993, Volume: 32, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Chromatography, High Pressure Liquid; Clinical Protocols; Cysteine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Patient Compliance; Penicillamine; Time Factors	1993
[Clinicopathological evaluation and treatment of bucillamine induced membranous nephropathy]. Ryumachi. [Rheumatism], 1993, Volume: 33, Issue:3 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Glomerulonephritis, Membranous; Humans; Kidney; Male; Middle Aged	1993
Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites. The Journal of rheumatology, 1993, Volume: 20, Issue:6 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Catalase; Cysteine; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Molecular Structure; T-Lymphocytes	1993
Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug. Clinical immunology and immunopathology, 1993, Volume: 66, Issue:1 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; B-Lymphocytes; Copper; Cysteine; Depression, Chemical; Humans; Immunoglobulin M; Lymphocyte Activation; Penicillamine	1993
[Bucillamin induced lung injury in rheumatoid arthritis]. Ryumachi. [Rheumatism], 1996, Volume: 36, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Diagnosis, Differential; Female; Humans; Lung Diseases; Male; Middle Aged; Tomography, X-Ray Computed	1996
Bucillamine induced pulmonary injury occurs with immunoglobulin decrease. The Journal of rheumatology, 1996, Volume: 23, Issue:7 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Lung Diseases; Lung Diseases, Interstitial; Radiography	1996
Generation of reactive oxygen species is required for bucillamine, a novel anti-rheumatic drug, to induce apoptosis in concert with copper. Immunopharmacology, 1997, Volume: 35, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Arthritis, Rheumatoid; Cell Line; Copper; Cysteine; Drug Synergism; Humans; Monocytes; Reactive Oxygen Species	1997
Differential influences of gold sodium thiomalate and bucillamine on the generation of CD14+ monocyte-lineage cells from bone marrow of rheumatoid arthritis patients. Clinical immunology and immunopathology, 1997, Volume: 84, Issue:3 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow; Bone Marrow Cells; Cell Lineage; Cysteine; Female; Gold Sodium Thiomalate; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes	1997
Induction of drug resistance to gold sodium thiomalate in a monocyte cell line, THP-1. Clinical rheumatology, 1998, Volume: 17, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line; Cysteine; Cytoplasm; Dose-Response Relationship, Drug; Drug Resistance; Fluorescent Antibody Technique, Indirect; Gold Sodium Thiomalate; Humans; Metallothionein; Monocytes; Sensitivity and Specificity	1998
Drug eruption due to bucillamine. Contact dermatitis, 1998, Volume: 39, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Drug Eruptions; Female; Humans; Middle Aged; Patch Tests	1998
Pharmacological effects of SA96 (bucillamine) and its metabolites as immunomodulating drugs--the disulfide structure of SA-96 metabolites plays a critical role in the pharmacological action of the drug. International journal of immunopharmacology, 1998, Volume: 20, Issue:6 Topics: Adjuvants, Immunologic; Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Cysteine; Disulfides; Female; Gas Chromatography-Mass Spectrometry; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Penicillamine; Rats; Structure-Activity Relationship; Synovial Fluid	1998
Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women. Clinical biochemistry, 1999, Volume: 32, Issue:1 Topics: Adult; Amino Acids; Arthritis, Rheumatoid; Cysteine; Female; Folic Acid; Glutathione; Glycine; Homocysteine; Humans; Middle Aged; Vitamin B 12	1999
[A case of rheumatoid arthritis with bucillamine-induced myasthenia gravis treated by immunoadsorption therapy]. Ryumachi. [Rheumatism], 1999, Volume: 39, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Immunosorbent Techniques; Middle Aged; Myasthenia Gravis	1999
The role of N-acetylcysteine in protecting synovial fluid biomolecules against radiolytically-mediated oxidative damage: a high field proton NMR study. Free radical research, 1999, Volume: 30, Issue:5 Topics: Acetylcysteine; Arthritis, Rheumatoid; Cysteine; Free Radicals; Gamma Rays; Humans; Knee Joint; Magnetic Resonance Spectroscopy; Oxidative Stress; Protons; Sulfhydryl Compounds; Synovial Fluid	1999
Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism. The Journal of rheumatology, 2000, Volume: 27, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; CD4-Positive T-Lymphocytes; Cell Differentiation; Cells, Cultured; Cysteine; Flow Cytometry; Humans; Hydrogen Peroxide; Interferon-gamma; Interleukin-12; Interleukin-2; Interleukin-4; Leukocyte Common Antigens; Oxidants; Penicillamine; Th1 Cells	2000
In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine. The Journal of rheumatology, 2000, Volume: 27, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Antirheumatic Agents; Apoptosis; Arthritis, Rheumatoid; B-Lymphocytes; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cysteine; Dexamethasone; Enterotoxins; Flow Cytometry; Glucocorticoids; Hybridomas; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Penicillamine; Reactive Oxygen Species; Superantigens; Thymus Gland	2000
Increased MDR1 P-glycoprotein expression in methotrexate resistance: comment on the article by Yudoh et al. Arthritis and rheumatism, 2000, Volume: 43, Issue:7 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cysteine; Drug Interactions; Drug Resistance, Multiple; Humans; Methotrexate; Sulfasalazine; Th1 Cells	2000
Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. The Journal of rheumatology, 2000, Volume: 27, Issue:10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Collagen; Cysteine; Drug Therapy, Combination; Endostatins; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Humans; Lymphokines; Middle Aged; Osteoarthritis; Peptide Fragments; Prednisolone; Sulfasalazine; Synovial Fluid; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000
Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology (Oxford, England), 2000, Volume: 39, Issue:11 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Cells, Cultured; Cysteine; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Endothelial Growth Factors; Fibroblast Growth Factor 2; Gold Sodium Thiomalate; Humans; In Vitro Techniques; Lipopolysaccharides; Lymphokines; Methotrexate; Sulfasalazine; Synovial Membrane; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000
[A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2001, Volume: 39, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Lung Diseases, Interstitial; Lymphocyte Activation; Middle Aged; Thoracic Surgery, Video-Assisted	2001
Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-Delta(12,14)-prostaglandin J2. Biochemical and biophysical research communications, 2001, May-18, Volume: 283, Issue:4 Topics: Arachidonic Acid; Arthritis, Rheumatoid; Chromans; Cyclooxygenase 2; Cysteine; Dinoprostone; Feedback; Humans; Isoenzymes; Leukotriene Antagonists; Leukotriene B4; Leukotrienes; Membrane Proteins; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Receptors, Cytoplasmic and Nuclear; Synovial Membrane; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone	2001
A case of BOOP developed during bucillamine treatment for rheumatoid. The Korean journal of internal medicine, 2001, Volume: 16, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biopsy, Needle; Cryptogenic Organizing Pneumonia; Cysteine; Follow-Up Studies; Humans; Male; Middle Aged; Radiography, Thoracic; Risk Assessment; Tomography, X-Ray Computed	2001
Bucillamine induces membranous glomerulonephritis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 39, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Dose-Response Relationship, Drug; Female; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Proteinuria	2002
[A case of rheumatoid arthritis complicated with a pneumonitis during concomitant treatment with methotrexate and bucillamine]. Ryumachi. [Rheumatism], 2002, Volume: 42, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cysteine; Female; Humans; Methotrexate; Pneumonia	2002
The inhibitory effect of D-penicillamine on human lymphocyte cultures stimulated by phytohaemagglutinin, the antagonistic action of L-cysteine and synergistic inhibition by copper sulphate. Scandinavian journal of rheumatology. Supplement, 1979, Issue:28 Topics: Adult; Arthritis, Rheumatoid; Blood; Cells, Cultured; Copper; Culture Media; Cysteine; Drug Synergism; Humans; Lymphocyte Activation; Penicillamine; Phytohemagglutinins	1979
Blood levels and side-effects of D-penicillamine. Agents and actions. Supplements, 1979, Issue:5 Topics: Arthritis, Rheumatoid; Copper; Cysteine; Humans; Kinetics; Penicillamine	1979
Proceedings: Antiarthritic properties of cystein derivatives in comparison with D-penicillamin in rats. Naunyn-Schmiedeberg's archives of pharmacology, 1975, Volume: 287 Suppl Topics: Animals; Arthritis, Rheumatoid; Cysteine; Elasticity; Female; Freund's Adjuvant; Penicillamine; Rats; Tendons	1975
[A case of bucillamine-induced pneumonitis]. Nihon Kyobu Shikkan Gakkai zasshi, 1992, Volume: 30, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Bronchoalveolar Lavage Fluid; Cysteine; Female; Gold Sodium Thiomalate; Lung; Pneumonia	1992
A case of rapidly progressive glomerulonephritis associated with bucillamine-treated rheumatoid arthritis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1992, Volume: 20, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biopsy; Cysteine; Female; Glomerulonephritis; Humans; Kidney; Microscopy, Electron; Middle Aged; Time Factors	1992
Bucillamine inhibits T cell adhesion to human endothelial cells. The Journal of rheumatology, 1992, Volume: 19, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Catalase; Cell Adhesion; Cell Communication; Cells, Cultured; Copper; Copper Sulfate; Cysteine; Endothelium, Vascular; Humans; Hydrogen Peroxide; Interferon-gamma; Recombinant Proteins; Superoxide Dismutase; T-Lymphocytes; Umbilical Veins	1992
[Lung injury associated with bucillamine therapy]. Ryumachi. [Rheumatism], 1992, Volume: 32, Issue:2 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Male; Middle Aged; Pulmonary Fibrosis	1992
Clinicopathological findings of bucillamine-induced nephrotic syndrome in patients with rheumatoid arthritis. American journal of nephrology, 1991, Volume: 11, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biopsy; Cysteine; Female; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Humans; Kidney; Male; Microscopy, Electron; Middle Aged; Nephrotic Syndrome	1991
[A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine]. Ryumachi. [Rheumatism], 1991, Volume: 31, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Drug Eruptions; Female; Humans; Middle Aged; Pemphigus	1991
[Membranous glomerulonephritis probably related to bucillamine therapy in two patients with rheumatoid arthritis]. Nihon Jinzo Gakkai shi, 1991, Volume: 33, Issue:6 Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Complement C3; Cysteine; Female; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Kidney; Male; Middle Aged	1991
[Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis]. Nihon Jinzo Gakkai shi, 1990, Volume: 32, Issue:7 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Glomerulonephritis, Membranous; Humans	1990
Decrease in disease activity and concomitant increase in the percentage of peripheral blood suppressor T-cells in rheumatoid arthritis by a newly synthesized slow-acting anti-rheumatic drug (Bucillamine). International journal of immunopharmacology, 1989, Volume: 11, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Leukocyte Count; Middle Aged; T-Lymphocytes, Regulatory; Time Factors	1989
A case of bullous pemphigoid induced by tiobutarit (D-penicillamine analogue). The Journal of dermatology, 1989, Volume: 16, Issue:4 Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cysteine; Female; Humans; Middle Aged; Pemphigoid, Bullous; Skin Diseases, Vesiculobullous	1989
Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel antirheumatoid drugs. International journal of clinical pharmacology research, 1985, Volume: 5, Issue:1 Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Viscosity; Captopril; Cysteine; Female; Humans; Male; Middle Aged; Penicillamine; Sulfasalazine; Sulfates; Zinc; Zinc Sulfate	1985
The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis. Clinical nephrology, 1986, Volume: 25, Issue:5 Topics: Arthritis, Rheumatoid; Cysteine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penicillamine; Renal Dialysis; Time Factors	1986
Methylcysteine in rheumatoid arthritis. British journal of rheumatology, 1986, Volume: 25, Issue:1 Topics: Arthritis, Rheumatoid; Cysteine; Humans	1986
A method for detecting Ig rheumatoid factors in seronegative rheumatoid arthritis. Archivum immunologiae et therapiae experimentalis, 1974, Volume: 22, Issue:3 Topics: Absorption; Animals; Antigens; Arthritis, Rheumatoid; Cysteine; Erythrocytes; gamma-Globulins; Hemagglutination Tests; Humans; Immunodiffusion; Immunoglobulin G; Immunoglobulins; Immunologic Techniques; Peptides; Polymers; Rabbits; Rheumatoid Factor; Serologic Tests	1974
Presence of a gelatin-specific proteinase and its latent form in human leucocytes. Biochimica et biophysica acta, 1974, Dec-29, Volume: 370, Issue:2 Topics: Arthritis, Rheumatoid; Chloromercuribenzoates; Chromatography, Gel; Chromatography, Ion Exchange; Collagen; Cysteine; Dithiothreitol; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Gelatin; Humans; Hydrogen-Ion Concentration; Hydroxyproline; Iodoacetates; Isoflurophate; Kinetics; Leukocytes; Peptide Hydrolases; Structure-Activity Relationship; Synovial Fluid; Temperature; Trypsin Inhibitors; Viscosity	1974
The influence of DL-cysteine on adenyl cyclase activity in rat thymocytes. Archivum immunologiae et therapiae experimentalis, 1974, Volume: 22, Issue:5 Topics: Adenylyl Cyclases; Animals; Arthritis, Rheumatoid; Cysteine; Disease Models, Animal; Epinephrine; Freund's Adjuvant; Injections, Intraperitoneal; Male; Rats; Rats, Inbred Strains; Thymus Gland; Time Factors	1974
Catecholamines in the lymphatic organs in rats with postadjuvant polyarthritis and after treatment with DL-cysteine hydrochloride. Archivum immunologiae et therapiae experimentalis, 1973, Volume: 21, Issue:3 Topics: Adrenal Glands; Animals; Arthritis, Rheumatoid; Catecholamines; Cysteine; Epinephrine; Female; Kidney; Liver; Lymph Nodes; Lymphatic System; Norepinephrine; Rats; Spleen; Thymus Gland; Time Factors	1973
Dermal connective tissue permeability in rheumatoid arthritics. Annals of the rheumatic diseases, 1966, Volume: 25, Issue:4 Topics: Adult; Animals; Arthritis, Rheumatoid; Ascorbic Acid; Carbamates; Cell Membrane Permeability; Connective Tissue; Cysteine; Dye Dilution Technique; Ethanol; Humans; Hyaluronic Acid; Injections, Intradermal; Isotonic Solutions; Penicillamine; Prednisone; Rats; Skin; Sodium Salicylate; Thiourea	1966
Serum sulfhydryl levels and rheumatoid factors in rheumatoid arthritis. The Tohoku journal of experimental medicine, 1970, Volume: 100, Issue:4 Topics: Adult; Arthritis, Rheumatoid; Cysteine; Female; Glutathione; Hemagglutination Tests; Humans; Immunoglobulin M; Lupus Erythematosus, Systemic; Male; Nephritis; Nephrotic Syndrome; Rheumatic Diseases; Rheumatic Fever; Rheumatoid Factor; Sulfhydryl Compounds; Synovial Fluid	1970
The molybdate urine test in determination of the activity of rheumatoid arthritis. Polish medical science and history bulletin, 1970, Volume: 13, Issue:4 Topics: Arthritis, Rheumatoid; Cell Division; Cysteine; Humans; Indicators and Reagents; Molybdenum; Oxidation-Reduction; Quaternary Ammonium Compounds; Urine	1970
Inhibition of heat-induced denaturation of serum proteins by mixtures of nonsteroidal anti-inflammatory agents and amino acids. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1968, Volume: 128, Issue:1 Topics: Amino Acids; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cysteine; Depression, Chemical; Flufenamic Acid; Fluorine; Histamine; Histidine; Hot Temperature; Indomethacin; ortho-Aminobenzoates; Phenylalanine; Phenylbutazone; Protein Denaturation; Serine; Serum Albumin, Bovine; Solutions; Tryptophan; Tyrosine	1968
Effects of SH-compounds on rheumatoid factors in rheumatoid arthritis. The Tohoku journal of experimental medicine, 1969, Volume: 97, Issue:3 Topics: Animals; Arthritis, Rheumatoid; Blood Protein Electrophoresis; Cysteine; Hemagglutination Tests; Humans; Injections; Joints; Penicillamine; Rabbits; Rheumatoid Factor; Serologic Tests; Sulfhydryl Compounds; Synovial Fluid; Ultracentrifugation; Viscosity	1969
Effects of lysosomal collagenolytic enzymes, anti-inflammatory drugs and other substances on some properties of insoluble collagen. The Biochemical journal, 1969, Volume: 113, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cathepsins; Collagen; Copper; Cysteine; Hydroxyproline; In Vitro Techniques; Lathyrism; Liver; Lysosomes; Mucoproteins; Penicillamine; Phenylacetates; Phenylbutazone; Rats; Solubility	1969